|
Jan
31 2012 Pacific Therapeutics Ltd. Terminates Irrevocable Subscription AgreementsOriginally posted in Fibrosis News Pacific Therapeutics Ltd. is a development stage specialty pharmaceutical company focused on the identification and development of drug candidates to treat diseases of excessive scarring .
Jan
31 2012 FDA Approves Kalydeco to Treat Rare Form of Cystic FibrosisOriginally posted in Fibrosis News CF is a serious genetic disorder affecting the lungs and other organs that ultimately leads to an early death.
Jan
31 2012 Kalydeco – A Cystic Fibrosis TreatmentOriginally posted in Cystic Fibrosis News From Medical News Today Kalydeco has been approved by the Food And Drug Administration (FDA) to treat a vicious type of Cystic Fibrosis (CF). CF is a deadly recessive disease which targets the lungs, but can also harm the liver, pancreas, and intestine. It occurs from the unusual transport of chloride and sodium across the epithelium, causing mucus buildup in the lungs, and thick secretions…
Jan
31 2012 Drug approved to treat cystic fibrosis’ root causeOriginally posted in Fibrosis News The first drug that treats the root cause of cystic fibrosis won approval Tuesday, offering a life-changing treatment for a handful of patients with the deadly illness and broader hope for thousands more patients with the inherited disease.
Jan
31 2012 Drug approved to treat cystic fibrosis’ root causeOriginally posted in Fibrosis News The first drug that treats the root cause of cystic fibrosis won approval Tuesday, offering a life-changing treatment for a handful of patients with the deadly illness and broader hope for thousands more patients with the inherited disease.
Jan
31 2012
Jan
31 2012 Mom to run half marathon to raise money, awareness for cystic fibrosisOriginally posted in Fibrosis News The Brantley family is seen in this photo. Pictured, back row from left, are Matthew, 21, and Kelli, 19; front row from left, are Stephanie; Kristen, 14; and Todd.
Jan
31 2012 Bronchoalveolar Lavage And Lung Clearance Index Detects Early Cystic Fibrosis Lung DiseaseOriginally posted in Cystic Fibrosis News From Medical News Today The lung clearance index (LCI) is a sensitive non-invasive marker of early lung disease in young children with cystic fibrosis (CF), according to a new study from Australian researchers…
|
|
©Uncle & Drunken Crayfish Productions 2011
www.DrunkenCrayfish.com
Visit our NEW site at
PocketBiker.com 
by Raelene
